NCT05664412 Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome
| NCT ID | NCT05664412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stephan Eliez |
| Condition | 22Q11 Deletion Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-10-20 |
| Primary Completion | 2026-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The purpose of this project is to explore the effects of transcranial alternating current stimulation (tACS) in children, adolescents and young adults with a 22q11.2 microdeletion. The main aim of the present research project is to investigate the effects of repeated, individually tuned high-density (HD) tACS on cognition (i.e., WM performance) and related neuroimaging markers in carriers of the 22q11DS. As cognitive deficits, most notably WM impairment, are among the earliest signs of psychotic disorders, interventions during adolescence aimed at reducing cognitive decline in at-risk individuals may prove effective in delaying or even preventing the later emergence of psychotic symptoms.
Eligibility Criteria
Inclusion Criteria: * Confirmed genetic diagnosis of 22q11DS * Age between 14 and 25 years old * Willingness to participate * Informed Consent signed by the subject and/or the caregiver(s) Exclusion Criteria: * Epilepsy * Deep brain stimulation electrodes * Traumatic brain injury * Facial metal implants